TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Pain perception during dental injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in distance walked in 6 minute Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HRQoL deterioration-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Persistent Postsurgical Pain (PPSP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post operative radiographic evidence of adequate reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial profile symmetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acromiohumeral Distance (AHD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in time needed to clinical improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower limb muscle soreness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of adverse cardiovascular and cerebrovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Recurrence rate of AP
Endpoint domain: Mortality/survival
Primary endpoint: Evaluation rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Vitamin D deficiency frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum thromboxane B2 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to return to normal function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Frequency of persistent symptoms
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Repeat hospitalizations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Functional Near-infrared Spectroscopy (fNIRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SMART-3RP group session attendance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Residual volume at 1st flow-stop
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Response rate and magnitude of CD4 and CD8 T-cell responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Complete Response (CR) and Very Good Partial Response (VGPR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change from baseline in MDM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of oxygen treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of time spent in hyperoxia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Concentration (Cmax) of Omaveloxolone in Breast Milk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Concentration Based on Area Under the Concentration-Time Curve (AUC [Cav]) of Omaveloxolone in Breast Milk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative Amount of Omaveloxolone Excreted in Breast Milk (Ae) Over 24 Hours (Ae0-24) Postdose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Patients Receiving Treatment Parameters
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Cmax of total iron and transferrin-bound iron
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t of total iron and transferrin-bound iron
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of people receiving HPV vaccine doses
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Early diabetes diagnosis, measured as HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of DKA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolic control after clinical diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Diagnostic yield from the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: all-cause 30-day mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: Initial or first-pass success rate of intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Recognition of facial emotions/body expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cortisol in response to acute stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Rates of surgical site infections (SSIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Agreement between vital sign data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Fully-Adherent to Buprenorphine
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of Participants Fully-Adherent to Care Plan
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of Participants Completing Outcomes Monitoring Surveys
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: AMAT
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of Participants with ACR20 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correction of Acidosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Correction of Hypercapnia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Management of Acute hypoxemic respiratory failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Correction of Hypoxemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Endotracheal intubation rate
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects with clinically significant bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Symptoms of simulator sickness
Endpoint domain: Adverse events/effects
Primary endpoint: Feasibility as assessed by paediatric participants
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Acceptability as assessed by paediatric participants
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Widespread Pain Index Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of 10m walk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of 6 min walk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Ground reaction force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Kinematics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of surface electromyography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bacterial population of the stool
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Accuracy of IPMN malignant transformation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Frequency of MAFLD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Opioid concentrations in hair samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opioid concentrations in sweat extracts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IQ (Intelligence Quotient) scoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reward sensitivity testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Health Questionnaire - PHQ9
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Generalised Anxiety Disorder Assessment - GAD 7
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Work and Social Adjustment Scale - WSAS
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Pharmacokinetic parameters of posaconazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aspergillus isolation from sputum cultures
Endpoint domain: Adverse events/effects
Primary endpoint: Regional Ventilation Delay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery time - Sick leave
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Protein composition in tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolomic composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of Health care services
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Use of psychotropic medications
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Prevalence of neurological morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Glutamate concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric Mean Titer (GMT) of Anti-Hemagglutinin (HA) Antibodies at Day 29
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Seroconversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Solicited Local and Systemic ARs
Endpoint domain: Adverse events/effects
Primary endpoint: Physical and Psychological Symptoms Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of Levodopa (LD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-Time Curve (AUC) for the 24-hour Interval of LD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimum Observed Plasma Concentration (Cmin) of Levodopa (LD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants experiencing DLT of submandibular pain
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of participants experiencing DLT as serious adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of participants experiencing DLT as pre-specified toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Intra-operative hypotension time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in micro-awakening index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite index of pain intensity and opioid consumption (PIOC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in ADAS-cog11 Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of first CT scan for bronchopulmonary cancer screening
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Complete sensory-motor block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Two Minutes Walk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant perception of treatment acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage change in TUG test time to 48 hours and 14 days post-intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in m. vastus lateralis (VL) cross-sectional area (CSA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change from baseline STAI score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Supratemporal Neural Response to Change in Acoustic-Phonetic Dimensions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Behavioral Impact of Change in Acoustic-Phonetic Dimensions
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Supratemporal Neural Response to Change in Listening Context
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Behavioral Impact of Change in Listening Context
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: PTSD Symptoms (Checklist)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patch adhesion properties
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified intubation difficulty scale score (mIDS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life in patients with genital lichen sclerosus
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Peak PAED score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bacterial diversity (alpha- and beta diversity indices)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative abundance of the bacterial taxa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of reporting patients
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Prognostic significance of circulating tumor cells (CTCs)
Endpoint domain: Mortality/survival
Primary endpoint: Intra-tumor heterogeneity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Total meal energy ordered
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total meal energy consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Accuracy of registration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurophysiologic measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Growth velocity (g/kg/d)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oligodendrocyte death
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mitochondrial dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean gene expression of TSPAN8 in goblet cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean expression of KRT8 in airway cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean expression of miR-141/200 family members in transitional secretory cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parental-assessed sleep quality
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 24-h melatonin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: First morning void melatonin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Overall illness severity rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return to usual daily activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Feeling recovered from RTI
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Deterioration score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acidic Level (pH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Bicarbonate level (HCO3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Clinician-Administered PTSD Scale for DSM-5 Total Severity Score (CAPS-5)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Post-Traumatic Stress Disorder Symptom Checklist for DSM-5 (PCL-5)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Columbia Suicide Severity Rating Scale (C-SSRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Suicide Behavior Questionnaire - Revised (SBQ-R)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of sets that failed due to unexplained hyperglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fracture and retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in Iowa Gambling Task score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: change in Human Temporal Bisection Task score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: change in Probabilistic Learning Task score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: change in Progressive Ratio Task score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: change in Continuous Performance Task score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: change in human Behavioral Pattern Monitor activity and exploration score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Fistula flow Evaluation at M6
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fistula flow Evaluation at M12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum plasma concentration (Cmax) of UCB0599 in Part A
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve from time 0 to the last quantifiable concentration (AUC(0-t)) of UCB0599 in Part A
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration-time curve from time 0 to infinity (AUC(inf)) of UCB0599 in Part A
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of postoperative functional recovery (QoR-40) score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Malpositions
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in cognition/behavior I
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in cognition/behavior II
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Post-transplant anti-A antibody titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Primary graft dysfunction grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to death or re-transplantation
Endpoint domain: Mortality/survival
Primary endpoint: Barthel index for activities of daily living
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Brunnstrom's hemiplegia recovery staging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Fugl-Meyer upper extremity assessment scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: ABILHAND stroke hand ability questionnaire assessment
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence of symptomatic and asymptomatic infection with SARS-CoV-2 and other respiratory viruses
Endpoint domain: Adverse events/effects
Primary endpoint: NDI (neck disability index)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Stabilometry assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in metabolic rate compared to baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in temperature among the top 10% of hottest pixels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in core temperature measured via oral thermometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaccination Attitudes Examination (VAX) Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: COVID-19 Prevention Health Behaviors
Endpoint domain: Life impact
Endpoint subdomain: Behavioral functioning
Primary endpoint: COVID-19 Knowledge and Attitudes
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Needlestick injury Risk Perception Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Concentration of Inflammatory Biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in uncontrolled allergic rhinitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Persisting anastomotic stricture resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of ERCPs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Visceral tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Distinguishing recurrent podocytopathies from healthy subjects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes